CorFlow Presents at the PCR Innovators Day and New Data During EuroPCR 2019
CorFlow Therapeutics AG ("CorFlow") today announced that the company will present the Controlled Flow Infusion (CoFI™) technology for diagnosis and treatment of microvascular obstruction in patients with myocardial infarction during the upcoming PCR Innovators Day, to be held in Paris, France. Mehr






